BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20011860)

  • 1. Influence of angiotensin-converting enzyme inhibitors on hypotension after anesthetic induction: is the preoperative discontinuation of this drug necessary?
    da Costa VV; Caldas AC; Nunes LG; Beraldo PS; Saraiva RA
    Rev Bras Anestesiol; 2009; 59(6):704-15. PubMed ID: 20011860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.
    Twersky RS; Goel V; Narayan P; Weedon J
    Anesth Analg; 2014 May; 118(5):938-44. PubMed ID: 24681657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
    Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery.
    Hasija S; Makhija N; Choudhury M; Hote M; Chauhan S; Kiran U
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):230-8. PubMed ID: 19875309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
    Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
    J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of angiotensin-converting enzyme inhibitor-associated refractory hypotension during the perioperative period.
    Thoma A
    AANA J; 2013 Apr; 81(2):133-40. PubMed ID: 23971233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis.
    Ling Q; Gu Y; Chen J; Chen Y; Shi Y; Zhao G; Zhu Q
    BMC Anesthesiol; 2018 Feb; 18(1):26. PubMed ID: 29482507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: results of a dose-comparison study.
    Shahzamani M; Yousefi Z; Frootaghe AN; Jafarimehr E; Froughi M; Tofighi F; Azadani AN; Pourhoseingholi MA; Azadani PN
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):185-91. PubMed ID: 19721131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors.
    Licker M; Schweizer A; Höhn L; Farinelli C; Morel DR
    Can J Anaesth; 2000 May; 47(5):433-40. PubMed ID: 10831200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Intraoperative Hypotension After the Induction of Anesthesia in Hypertensive Patients with Preoperative Angiotensin-converting Enzyme Inhibitors.
    Salim F; Khan F; Nasir M; Ali R; Iqbal A; Raza A
    Cureus; 2020 Jan; 12(1):e6614. PubMed ID: 32064194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
    Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
    Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U; Melina G; Capuano F; Comito C; Bianchini R; Simon C; Refice S; Angeloni E; Sinatra R
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1098-103. PubMed ID: 18852580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial hypotension in myocardial revascularization surgery: influence of angiotensin-converting enzyme inhibitors.
    Jordão MG; dos Santos AT
    Rev Bras Anestesiol; 2002 Apr; 52(2):211-8. PubMed ID: 19475215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of hypotension during anesthesia induction in patients with hypertension on medication: a retrospective observational study.
    Hojo T; Kimura Y; Shibuya M; Fujisawa T
    BMC Anesthesiol; 2022 Nov; 22(1):343. PubMed ID: 36368916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin-converting enzyme inhibitors and anesthesia].
    Larsen JK; Nielsen MB; Jespersen TW
    Ugeskr Laeger; 1996 Oct; 158(43):6081-4. PubMed ID: 8928292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and discontinuation of angiotensin converting enzyme inhibitors: current perspectives.
    Bradic N; Povsic-Cevra Z
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):50-54. PubMed ID: 29206698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors.
    Morimoto T; Gandhi TK; Fiskio JM; Seger AC; So JW; Cook EF; Fukui T; Bates DW
    J Eval Clin Pract; 2004 Nov; 10(4):499-509. PubMed ID: 15482412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.